BFM
MYOV

Boothbay Fund Management’s Myovant Sciences Ltd. MYOV Stock Holding History

Boothbay Fund Management’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10,238
Closed -$190K – 1302
2020
Q2 		$211K Sell
10,238
-33,437
-77% -$455K 0.01% 788
2020
Q1 		$330K Buy
+43,675
New +$490K 0.03% 547
2019
Q4 		– Sell
-19,725
Closed -$103K – 1051
2019
Q3 		$103K Buy
+19,725
New +$146K 0.01% 701

Other funds holding MYOV

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $606M AUM 63.41% 1-Year Est. Return

Boothbay Fund Management's MYOV Position: Q3 2020 in Review

Boothbay Fund Management sold out of Myovant Sciences Ltd. (MYOV) in Q3 2020, closing a stake of 10,238 shares — an estimated $190K sold.

Boothbay Fund Management first reported a position in MYOV in Q3 2019 and held it in 3 quarters. The position peaked at $330K in Q1 2020. 102 funds tracked by Wall St. Rank hold MYOV as of Q3 2020.

  • Boothbay Fund Management reported no remaining Myovant Sciences Ltd. position as of Q3 2020 after selling out during the quarter.
  • Boothbay Fund Management sold 10,238 Myovant Sciences Ltd. shares in Q3 2020, an estimated $190K.
  • Boothbay Fund Management first reported a position in Myovant Sciences Ltd. in Q3 2019 and held it in 3 quarters.
  • Boothbay Fund Management's Myovant Sciences Ltd. position peaked at $330K in Q1 2020.
  • 102 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q3 2020.

Based on Boothbay Fund Management's 13F filing for Q3 2020, filed 16 Nov 2020.